PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Oral administration of A. hypochondriacus proteins in rats suggested an inhibition of thrombus formation [PMID:26627100].
Amaranth products are evaluated as a high-nutritional value option for gluten-free diets in children [PMID:39396211].
Amaranth flour and isolated proteins in rats increased fecal cholesterol excretion and decreased hepatic cholesterol [PMID:31599971].
Lunasin from amaranth seeds induced apoptosis against HeLa cells [PMID:18211015].
Evidence summary
PubMed sources
- 1.PMID: 39519742 (2024) — Purification, Structural Characterization, and Bioactivity of Amaranthus hypochondriacus Lectin. · Molecules (Basel, Switzerland)
- 2.PMID: 25831476 (2017) — Structures, physicochemical properties, and applications of amaranth starch. · Critical reviews in food science and nutrition
- 3.PMID: 34995961 (2022) — Amaranthus hypochondriacus seeds as a rich source of cysteine rich bioactive peptides. · Food chemistry
- 4.PMID: 36738021 (2023) — Amaranth proteins and peptides: Biological properties and food uses. · Food research international (Ottawa, Ont.)
- 5.PMID: 26627100 (2016) — Antithrombotic Effects of Amaranthus hypochondriacus Proteins in Rats.